Lantern Pharma Inc
(LTRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,363 | -8,823 | -4,769 | -2,452 | -5,908 |
| Depreciation Amortization | 147 | 5 | 3 | 1 | 3 |
| Other Working Capital | 600 | -377 | 490 | 61 | -939 |
| Other Operating Activity | 1,024 | 643 | 406 | 246 | 1,192 |
| Operating Cash Flow | $-10,592 | $-8,553 | $-3,870 | $-2,144 | $-5,652 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,515 | -19,281 | -18,282 | N/A | N/A |
| PPE Investments | -16 | -16 | -12 | N/A | -16 |
| Investing Cash Flow | $-19,531 | $-19,297 | $-18,294 | $N/A | $-16 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 169 |
| Debt Issued | N/A | N/A | N/A | N/A | 109 |
| Common Stock Issued | 69,140 | 69,073 | 69,073 | 69,073 | 26,302 |
| Common Stock Repurchased | -940 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -4,784 | -4,784 | -4,784 | -4,784 | -2,914 |
| Financing Cash Flow | $63,416 | $64,289 | $64,289 | $64,289 | $23,665 |
| Exchange Rate Effect | 1 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 19,229 | 19,229 | 19,229 | 19,229 | 1,232 |
| End Cash Position | 52,524 | 55,669 | 61,354 | 81,374 | 19,229 |
| Net Cash Flow | $33,295 | $36,440 | $42,125 | $62,145 | $17,997 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,592 | -8,553 | -3,870 | -2,144 | -5,652 |
| Capital Expenditure | -16 | -16 | -12 | N/A | -16 |
| Free Cash Flow | -10,607 | -8,568 | -3,882 | -2,144 | -5,668 |